Authors
Latest:
Open-Label Study Finds Aficamten Could Help Most oHCM Patients Avoid SurgeryAhmad Masri, MD, MS, discusses data from the FOREST-HCM trial examining effects of aficamten in patients with oHCM eligible for septal reduction therapy at baseline.
Latest:
Brett Nowlan, MD: My Year Working During a PandemicA lipidologist from Connecticut describes his experience during the COVID-19 pandemic and explains why he sees getting the vaccine as his "biggest contribution" to healthcare during the pandemic.
Latest:
Final Thoughts on Treatment of AsthmaRaffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Latest:
Steroids and Immunosuppressive Agents for CSUPanelists discuss how steroids can play a role in the management of chronic spontaneous urticaria (CSU), while emphasizing that practitioners should exercise caution due to potential adverse effects and the need for careful monitoring when using systemic steroids.
Latest:
Key Takeaways for Lipid Lowering in Hypercholesterolemia and ASCVDDrs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.
Latest:
Qazi Corner, Edition 7: ERCP Timing, GLP-1 RA Considerations, Seronegative Villous AtrophyThe third quarterly issue of 2024 reviews early versus late ERCP outcomes post-transplant, the impact of GLP-1RA use on endoscopic management, and the differential diagnosis of seronegative villous atrophy.
Latest:
Current Barriers to uACR TestingPanelists discuss the current barriers to urine albumin-creatinine ratio (uACR) testing, strategies to address these barriers, the guideline goals for reducing uACR, and the importance of a multimodal approach, as well as how increased awareness of chronic kidney disease (CKD) testing can improve patient outcomes and engage health care providers in promoting testing.
Latest:
Restarting Therapy in Patients with HIVAddressing patients with HIV who have fallen out of care, Shauna Applin, ARNP, provides clinical insights on treatment options and best practices for restarting therapy.
Latest:
Gout Isn’t a Punchline. It’s Time to Stop Treating it Like One.As an industry and a society, we must take gout more seriously. That effort begins with the physicians who diagnose and treat it.
Latest:
Lung Microbiome Profiling: A Promising Approach to Enhance Diagnostic Precision for Ventilator-Associated PneumoniaInterim results of the LUCID-IMHO study provide insights into the microbiome dynamics of critically ill patients with VAP.
Latest:
The APAC Recap: Lifestyle Medicine at CAPP Live 2024 with Laura Ross, PA-CLaura Ross, PA-C, shares insights from the inaugural CAPP meeting on how lifestyle medicine and targeted therapies are transforming cardiovascular care.
Latest:
Advice for Sickle Cell Disease ManagementSophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
Latest:
Diabetes Dialogue: News and Updates in Diabetes at AHA 2024In this episode, hosts break down a pair of studies from AHA 2024, BPROAD and SUMMIT, as well as a study in JAMA projecting semaglutide eligibility in US adults.
Latest:
The Important, Evolving Role of Pharmacists in Helping Patients Quit SmokingMore than two-thirds of smokers want to quit, but lack proper resources. A prescribing professional could help make up that difference.
Latest:
Harnessing Patient Insights: The Role of PROs in Managing Psoriasis and Psoriatic ArthritisThis feature highlights the views of 3 experts on the integration of patient-reported outcomes into the management of psoriatic disease.
Latest:
Improving Strategies for Management of Primary Biliary CholangitisIn this video segment, Palak and Trivedi discuss strategies for improving the management of patients in real-world settings given recent advances in therapies and pathophysiology.
Latest:
New ICD-10 Code is An Important Milestone for Rare Disease PatientsThe introduction of an ICD-10 code specific to IgG4-Related Disease offers a promising opportunity to revolutionize patient care, enable more accurate diagnoses, and improve outcomes.
Latest:
Supporting Adolescents and Young Adults in Managing Type 1 DiabetesIn this episode of MEDcast, Dr Julia Blanchette joins Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, discuss strategies to empower young adults with the skills and resources necessary to effectively manage type 1 diabetes and maintain a healthy lifestyle.
Latest:
Bridging the Gap for T1D ManagementExpert endocrinologists provide final thoughts on addressing unmet needs and improving the management of T1D.
Latest:
Unmet Needs, Future Research in Schizophrenia and Muscarinic AgonistsIn part 5 of 5, experts discuss ongoing unmet needs and future research priorities in schizophrenia management.
Latest:
How Pharmaceutical Innovation is Saving the World from COVID-19The US and the world must appreciate the role of the pharmaceutical industry who are rescuing the world from COVID-19—the medical breakthrough of our lifetime.
Latest:
Selecting CD Treatment in Special ScenariosExperts in gastroenterology discuss treatment selection in special situations of CD, such as age, women considering pregnancy, and extra-intestinal manifestations.
Latest:
Understanding NUDGLE-FLU Data from AHA 2024, with Ankeet Bhatt, MD, MBA, ScMAnkeet Bhatt, MD, MBA, ScM, provides additional insight into NUDGE-FLU data he presented at AHA 2024.
Latest:
FDA Approves New Neuromyelitis Optica Spectrum Disorder TreatmentSatralizumab represents only the second targeted treatment for NMOSD and the first cleared for at-home administration.
Latest:
Anti-VEGF for RVO: The Gold StandardJohn W Kitchens, MD, bookends the discussion by highlighting the landscape of branch vein occlusion (BRVO) treatment options.
